title: SARS coronavirus vaccine development.
authors.affiliation: University of North Carolina at Chapel Hill, 27599, USA.
authors.forename: Ralph S
authors.initials: RS
authors.lastname: Baric
authors.forename: Timothy
authors.initials: T
authors.lastname: Sheahan
authors.forename: Damon
authors.initials: D
authors.lastname: Deming
authors.forename: Eric
authors.initials: E
authors.lastname: Donaldson
authors.forename: Boyd
authors.initials: B
authors.lastname: Yount
authors.forename: Amy C
authors.initials: AC
authors.lastname: Sims
authors.forename: Rhonda S
authors.initials: RS
authors.lastname: Roberts
authors.forename: Matthew
authors.initials: M
authors.lastname: Frieman
authors.forename: Barry
authors.initials: B
authors.lastname: Rockx
mesh_terms: D000818:Animals; D019143:Evolution, Molecular; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008957:Models, Genetic; D009500:Neutralization Tests; D019590:Nucleocapsid Proteins / Q000378:metabolism; D010802:Phylogeny; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics*; D045169:Severe Acute Respiratory Syndrome / Q000517:prevention & control*; D014759:Viral Envelope Proteins / Q000378:metabolism; D014765:Viral Vaccines
chemical_list: D019590:Nucleocapsid Proteins; D014759:Viral Envelope Proteins; D014765:Viral Vaccines